Evaluating the relationship between therapeutic anticoagulation, abnormal uterine bleeding, and gynecologic management - 09/03/23
Doi : 10.1016/j.ajog.2022.12.075
X. Brioso 1, M. Bolt 2, M. Sammel 2, K. McKenney 3
1 Department of Obstetrics, Gynecology and Reproductive Sciences, Yale New Haven Hospital, New Haven, CT
2 Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado-Denver Anschutz Medical Campus, Denver, CO
3 Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Denver, CO
35
Le texte complet de cet article est disponible en PDF.Plan
| DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS: Xiomara Brioso: Nothing to disclose; Matthew Bolt: Nothing to disclose; Mary Sammel: Nothing to disclose; Kathryn McKenney: Nothing to disclose. |
© 2022
Publié par Elsevier Masson SAS.
Vol 228 - N° 3S
P. S838-S839 - mars 2023 Retour au numéro
Article précédent
- Impact of midurethral sling at time of prolapse surgery on overactive bladder symptoms and urinary biomarkers
- J.T. Kowalski, E. Maetzold, K. Kenne, C. Bradley
- Surgeon specialty and postoperative outcomes following sling surgery for stress urinary incontinence
- K.J. Warner, O. Brown, J.F. Pennycuff, C.E. Bretschneider
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?